SYRE
Spyre Therapeutics, Inc.Company with tickers: SYRE
CIK
1636282
CUSIP
00773J202
Shares Outstanding
86,259,358
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | Turtle Cameron | Director | Sell | 12,344 |
| 2026-04-01 | Sloan Sheldon | Chief Medical Officer | Convert | 7,958 |
| 2026-04-01 | Sloan Sheldon | Chief Medical Officer | Sell | 7,958 |
| 2026-04-01 | Sloan Sheldon | Chief Medical Officer | Convert | 7,958 |
| 2026-04-01 | Burrows Scott L | Chief Financial Officer | Sell | 6,200 |
| 2026-04-01 | Burrows Scott L | Chief Financial Officer | Convert | 7,500 |
| 2026-04-01 | Burrows Scott L | Chief Financial Officer | Convert | 7,500 |
| 2026-03-03 | Burrows Scott L | Chief Financial Officer | Convert | 2,500 |
| 2026-03-03 | Burrows Scott L | Chief Financial Officer | Sell | 2,300 |
| 2026-03-03 | Burrows Scott L | Chief Financial Officer | Convert | 2,500 |
| 2026-03-02 | Turtle Cameron | Director | Sell | 5,900 |
| 2026-02-02 | Turtle Cameron | Director | Sell | 957 |
| 2026-01-21 | HENDERSON MICHAEL THOMAS | Chief Business Officer | Other | 63,227 |
| 2026-01-09 | Burrows Scott L | Chief Financial Officer | Award | 140,000 |
| 2026-01-09 | Turtle Cameron | Director | Award | 528,000 |
| 2026-01-09 | Sloan Sheldon | Chief Medical Officer | Award | 140,000 |
| 2026-01-09 | King-Jones Heidy | See Remarks | Award | 140,000 |
| 2026-01-02 | Turtle Cameron | Director | Sell | 12,709 |
| 2025-12-01 | Turtle Cameron | Director | Sell | 10,995 |
| 2025-11-03 | Turtle Cameron | Director | Sell | 28,155 |
| 2025-09-02 | Burrows Scott L | Chief Financial Officer | Sell | 18,428 |
| 2025-05-29 | Fairmount Funds Management LLC | Director | Award | 25,000 |
| 2025-05-29 | Stelzer Laurie | Director | Award | 25,000 |
| 2025-05-29 | Milligan Sandra | Interim CEO & President | Award | 25,000 |
| 2025-05-29 | McKenna Mark C. | Director | Award | 25,000 |
| 2025-05-29 | HENDERSON MICHAEL THOMAS | Chief Business Officer | Award | 25,000 |
| 2025-05-29 | Albers Jeffrey W. | Director | Award | 25,000 |
| 2025-01-15 | Burrows Scott L | Chief Financial Officer | Award | 95,500 |
| 2025-01-15 | Sloan Sheldon | Chief Medical Officer | Award | 95,500 |
| 2025-01-15 | Turtle Cameron | Director | Award | 370,000 |
| 2025-01-15 | King-Jones Heidy | See Remarks | Award | 95,500 |
| 2025-01-10 | HENDERSON MICHAEL THOMAS | Chief Business Officer | Other | 105,379 |
| 2024-11-06 | Albers Jeffrey W. | Director | Sell | 6,700 |
| 2024-10-25 | Albers Jeffrey W. | Director | Sell | 300 |
| 2024-10-01 | Sloan Sheldon | Chief Medical Officer | Award | 400,000 |
| 2024-10-01 | Sloan Sheldon | Chief Medical Officer | Other | 0 |
| 2024-09-03 | Burrows Scott L | Chief Financial Officer | Sell | 18,531 |
| 2024-05-14 | Fairmount Funds Management LLC | Director | Award | 11,323 |
| 2024-05-14 | Milligan Sandra | Interim CEO & President | Award | 21,980 |
| 2024-05-14 | Albers Jeffrey W. | Director | Award | 11,323 |
| 2024-05-14 | Stelzer Laurie | Director | Award | 11,323 |
| 2024-05-14 | HENDERSON MICHAEL THOMAS | Chief Business Officer | Award | 11,323 |
| 2024-05-14 | Milligan Sandra | Interim CEO & President | Other | 0 |
| 2024-04-25 | Fairmount Funds Management LLC | Director | Convert | 3,639,680 |
| 2024-04-25 | Fairmount Funds Management LLC | Director | Other | 406,038 |
| 2024-04-25 | Fairmount Funds Management LLC | Director | Convert | 90,992 |
| 2024-02-15 | Turtle Cameron | Director | Award | 400 |
| 2024-02-01 | McKenna Mark C. | Director | Award | 40,000 |
| 2024-02-01 | Turtle Cameron | Director | Award | 277,750 |
| 2024-02-01 | Burrows Scott L | Chief Financial Officer | Award | 70,000 |
| 2024-02-01 | King-Jones Heidy | See Remarks | Award | 63,000 |
| 2024-02-01 | McKenna Mark C. | Director | Other | 0 |
| 2023-12-29 | Fairmount Funds Management LLC | Director | Other | 3,435,480 |
| 2023-12-29 | Fairmount Funds Management LLC | Director | Other | 437,037 |
| 2023-12-29 | Fairmount Funds Management LLC | Director | Other | 16,667 |
| 2023-12-22 | Burrows Scott L | Chief Financial Officer | Award | 134,953 |
| 2023-12-07 | Fairmount Funds Management LLC | Director | Award | 16,667 |
| 2023-11-24 | Fairmount Funds Management LLC | Director | Other | 85,887 |
| 2023-11-24 | Fairmount Funds Management LLC | Director | Other | 3,435,480 |
| 2023-11-24 | Turtle Cameron | Director | Other | 723,440 |
| 2023-11-24 | Turtle Cameron | Director | Other | 18,086 |
| 2023-11-22 | Albers Jeffrey W. | Director | Award | 50,000 |
| 2023-11-22 | Stelzer Laurie | Director | Award | 50,000 |
| 2023-11-22 | Turtle Cameron | Director | Award | 374,000 |
| 2023-11-22 | Albers Jeffrey W. | Director | Other | 0 |
| 2023-11-22 | Stelzer Laurie | Director | Other | 0 |
| 2023-09-01 | Burrows Scott L | Chief Financial Officer | Award | 10,121,441 |
| 2023-09-01 | King-Jones Heidy | See Remarks | Other | 0 |
| 2023-09-01 | King-Jones Heidy | See Remarks | Award | 13,495,255 |
| 2023-09-01 | Burrows Scott L | Chief Financial Officer | Other | 0 |
| 2023-06-22 | Magovcevic-Liebisch Ivana | Director | Award | 1,950,000 |
| 2023-06-22 | Smith Hunter C | Chief Financial Officer | Award | 1,950,000 |
| 2023-06-22 | Alspaugh Jonathan | President and CFO | Award | 19,787,969 |
| 2023-06-22 | Lawton Alison Frances | Director | Award | 1,950,000 |
| 2023-06-22 | Turtle Cameron | Director | Other | 0 |
| 2023-06-22 | Turtle Cameron | Director | Other | 0 |
| 2023-06-22 | Turtle Cameron | Director | Other | 576,699 |
| 2023-06-22 | HENDERSON MICHAEL THOMAS | Chief Business Officer | Other | 0 |
| 2023-06-22 | Cox Russell J. | Director | Award | 1,950,000 |
| 2023-06-22 | Fairmount Funds Management LLC | Director | Other | 0 |
| 2023-06-22 | Fairmount Funds Management LLC | Director | Other | 0 |
| 2023-06-22 | Fairmount Funds Management LLC | Director | Other | 276,082 |
| 2023-02-23 | Neuman Linda L | Chief Medical Officer | Award | 550,000 |
| 2023-02-23 | Kastenmayer James Paul | General Counsel | Award | 500,000 |
| 2023-02-23 | Hanley Jr. Michael Conick | Chief Business Officer | Award | 500,000 |
| 2023-02-23 | Alspaugh Jonathan | President and CFO | Award | 640,000 |
| 2022-11-29 | Goldberg Jeff Marc | Director, President and CEO | Other | 0 |
| 2022-11-29 | Goldberg Jeff Marc | Director, President and CEO | Award | 1,884,838 |
| 2022-11-14 | Neuman Linda L | Chief Medical Officer | Award | 25,000 |
| 2022-11-14 | Neuman Linda L | Chief Medical Officer | Other | 4,000 |
| 2022-11-14 | Neuman Linda L | Chief Medical Officer | Other | 0 |
| 2022-08-25 | Souza Marcio | Chief Operating Officer | Buy | 90,000 |
| 2022-08-23 | Kastenmayer James Paul | General Counsel | Award | 130,000 |
| 2022-08-23 | Alspaugh Jonathan | President and CFO | Award | 130,000 |
| 2022-08-23 | Kastenmayer James Paul | General Counsel | Other | 0 |
| 2022-08-23 | Kastenmayer James Paul | General Counsel | Other | 4,000 |
| 2022-08-23 | Sloan Leslie | Chief Operating Officer | Award | 130,000 |
| 2022-08-23 | Hanley Jr. Michael Conick | Chief Business Officer | Award | 130,000 |
| 2022-06-08 | Hanley Jr. Michael Conick | Chief Business Officer | Buy | 28,200 |
| 2022-06-07 | Shanafelt Armen | Director | Award | 43,000 |